Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cells and platelet-rich plasma for knee osteoarthritis
RBR-2fr526nCompleted
- Sponsor
- Universidade Federal de Mato Grosso do Sul
- Start
- Jun 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of adipose derived mesenchymal stromal cells and platelet-rich plasma in knee osteoarthritis (OA) (4 arms), sponsored by Universidade Federal de Mato Grosso do Sul. Started Jun 2018; status: completed.
02
Drugs
adipose derived mesenchymal stromal cellsplatelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on RBR-2fr526n.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2fr526n.